Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017105
Sloan Kettering Institute
Search grants from Sloan Kettering Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Early life influences on Epigenetic Aging in Mexican-American children
Defining cutoffs for the Point-of-Care Circulating Cathodic Antigen (POC CCA) assay in areas of low Schistosoma mansoni prevalence in western Kenya
West Virginia Conformance with Voluntary National Retail Food Regulatory Program Standards
Tulane University PRC
The National Web Site for Minority Scientists
Recently added grants:
Lipid Antigens for iNKT Cells in the Gut Microenvironment
Single-Cell Analysis To Define Protective and Tolerizing Immune Cell Populations in the Human Placenta
Human B1-like Cells and Pneumococcal Defense in the Elderly
Maternal regulation of diet-induced obesity in offspring.
Mechanisms of improved organ function following sepsis treatment with vitamin c, thiamine and hydrocortisone (triple therapy)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017105-005
Application #
6828837
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Sloan Kettering Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
Comments
Be the first to comment on this grant